null

Biotinylated Anti-CD22 (Pinatuzumab biosimilar) mAb (HDBS0245)

SKU:
HDBS0245
Antibody Type:
Biotinylated Biosimilar
Modifications:
Biotinylated
Applications:
IHC
SPR
FC
ELISA
Drug Development
Pharmacokinetics
Disease Area:
Cancer
Size:
100 μg
Target:
CD22
Isotype:
IgG1
Host Species:
Humanized
Reactivity:
Human
€429

Description

system_update_altDatasheetsystem_update_altMSDS
Product Name:Biotinylated Anti-CD22 (Pinatuzumab biosimilar) mAb
SKU:HDBS0245
Size:100 μg
Target:CD22
Common Name:ACD22-VCMMAE, DCDT2980S, FCU2803, RG-7593, RO5541072-000
Isotype:IgG1
Host Species:Humanized
Reactivity:Human
Synonyms:CD22;SIGLEC2;BL-CAM;SIGLEC-2;Siglec2;SIGLEC2FLJ22814
Applications:ELISA  Flow Cyt
Recommended Dilutions:ELISA 1:5000-10000; Flow Cyt 1:100
Conjugate:Biotinylated

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Uniprot:P20273
Formulation & Reconstitution:Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
Usage:Research use only
Storage & Shipping:Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Related Products